KARA RICHEY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health CLEVELAND, OH NPI 1710525035

General Payments — all program years on this page

$1,580.56

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 53
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $522.51 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $522.5121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $383.285
2022 $388.6511
2023 $286.1216
2024 $522.5121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078495726 Janssen Biotech, Inc. $18.70 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080613842 Verity Pharmaceuticals Inc. $16.34 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080613846 Verity Pharmaceuticals Inc. $16.66 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086305072 Bayer Healthcare Pharmaceuticals Inc. $15.00 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203583 Novartis Pharmaceuticals Corporation $16.32 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203591 Novartis Pharmaceuticals Corporation $18.64 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203593 Novartis Pharmaceuticals Corporation $23.14 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203599 Novartis Pharmaceuticals Corporation $25.82 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101234313 E.R. Squibb & Sons, L.L.C. $18.13 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104335396 AstraZeneca Pharmaceuticals LP $14.38 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108084794 ABBVIE INC. $16.14 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110807512 Eisai Inc. $23.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131278443 PFIZER INC. $17.58 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131357526 PFIZER INC. $20.57 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131827752 PFIZER INC. $17.80 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133709653 Gilead Sciences, Inc. $19.23 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139540576 Astellas Pharma US Inc $22.16 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141634329 Merck Sharp & Dohme LLC $14.00 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141634331 Merck Sharp & Dohme LLC $17.93 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141950357 Merck Sharp & Dohme LLC $16.91 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148990558 Sumitomo Pharma America, Inc. $154.06 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.